researchs

Recon

Josh SandbergOctober 20, 2015
1,509

Ember Therapeutics Announce Initial Positive Results From a Phase 2 Trial of BMP-7 in Patients with Moderate Osteoarthritis of the Knee

NEW YORK, Oct. 19, 2015 /PRNewswire/ — Ember Therapeutics, Inc., a privately held, New York-based biopharmaceutical company that is developing targeted therapies for osteoarthritis,…
Read More »
Financial

Josh SandbergOctober 7, 2015
1,277

Xtant(TM) Medical Awarded Grant From the Montana Board of Research and Commercialization Technology

BELGRADE, Mont., Oct. 06, 2015 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (OTCQX:BONE), a leader in the development of regenerative…
Read More »
Recon

Josh SandbergSeptember 8, 2015
1,273

Stability was similar after anatomic double-bundle ACLR in knees with differing amounts of hyperextension

By Monica Jaramillo Recently published data showed that anatomic double-bundle ACL reconstruction in cases of extreme knee hypertension may result…
Read More »
Spine

Josh SandbergSeptember 2, 2015
1,172

5 key notes on narcotics use for spine surgery workers’ compensation patients

By Laura Dyrda A new study published in Spine examines the postoperative narcotic consumption among workers’ compensation patients after minimally invasive transforaminal…
Read More »
Extremities

Josh SandbergAugust 27, 2015
1,742

SPR Therapeutics Awarded $1.6M NIH Grant to Study Pain Management Following Knee Replacement Surgery Using the Sprint™ PNS System

CLEVELAND, OH–(Marketwired – Aug 25, 2015) – SPR® Therapeutics has been awarded a $1.6M grant from the National Institute on…
Read More »
Sports Medicine

Josh SandbergAugust 6, 2015
1,129

Pitchers’ blood flow decreased in provocative shoulder position

By Casey Tingle After one competitive baseball season, the blood flow of pitchers significantly decreased when in a provocative shoulder…
Read More »
Extremities

Josh SandbergAugust 6, 2015
3,357

Low complication rates, excellent clinical outcomes observed with anterior approach THA

By Monica Jaramillo Recently published findings demonstrated low rates of perioperative complications and excellent clinical outcomes were observed in patients…
Read More »
Biologics

Josh SandbergJuly 23, 2015
1 1,840

BIODEGRADABLE IMPLANT METALS – NEXT BIG THING?

By Biloine Young It is hazardous to try to predict the “next big thing” in medicine, but the National Science Foundation…
Read More »

researchs

Ember Therapeutics Announce Initial Positive Results From a Phase 2 Trial of BMP-7 in Patients with Moderate Osteoarthritis of the Knee

Xtant(TM) Medical Awarded Grant From the Montana Board of Research and Commercialization Technology

Stability was similar after anatomic double-bundle ACLR in knees with differing amounts of hyperextension

5 key notes on narcotics use for spine surgery workers’ compensation patients

SPR Therapeutics Awarded $1.6M NIH Grant to Study Pain Management Following Knee Replacement Surgery Using the Sprint™ PNS System

Pitchers’ blood flow decreased in provocative shoulder position

Low complication rates, excellent clinical outcomes observed with anterior approach THA

BIODEGRADABLE IMPLANT METALS – NEXT BIG THING?

New Study from HSS Reveals Minimally Invasive Procedure Can Delay Arthritis in Select Patients with Hip Impingement

Four mega mergers helped increase M&A in Q1

Sports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings.